RSV Vaccination in Immunocompromised Patients.
RSV Vaccination in Immunocompromised Patients.
Recruiting · NCT06597916 · Registry updated 2024-11-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RSV Vaccination in Immunocompromised Patients. | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 2 | 2024-11-27 | NCT06597916 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| Medical University of Vienna | 195 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Specific Prophylaxis and Tropical Medicine, CePII, Medical university of Vienna | Vienna | Austria | 1 |